• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1, AND HEMIN; MULTIPURPOSE CULTURE MEDIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1, AND HEMIN; MULTIPURPOSE CULTURE MEDIUM Back to Search Results
Catalog Number 221788
Device Problem Output Problem (3005)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/15/2019
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
Customer reported that the bd bbl¿ thioglycollate medium had non-viable organisms (long thin gram negative rods) seen in the gram stains of patient samples.
 
Manufacturer Narrative
H.6.Investigation summary: this product is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 9150847 was satisfactory and no notifications were generated during manufacturing and inspection.Formulation, filling and autoclaving processes were within specifications.Qc inspection and testing were satisfactory at time of release.The release testing that is performed on this product does include review of its color and clarity.Samples submitted are examined to ensure that they conform to typical levels.The appearance of this batch was satisfactory per internal procedures.Direct staining techniques are not part of qc release testing for this product.Additionally as part of the release criteria for this product, the bhr is reviewed to confirm the following: the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.All autoclave parameters conformed to the validated cycle parameters for this product.The minimum f0 for this product was met.The complaint history was reviewed and other complaints have been taken on this batch for appearance but are also unconfirmed.Retention samples from batch 9150847 were available for inspection.No cap, tube or media defects were observed in 10/10 retention tubes.No appearance defects or microbial growth were found in the retention samples.Returns were received for investigation.Thirty-four tubes from batch 9150847 in a 100pack carton (#0545) were shipped in a box with air bubbles.No cap, tube or media defects were observed in 34/34 return tubes from visual inspection.For investigation of this complaint, retention and return samples were gram stained by two methods: 1) directly dropping the media on a slide and 2) by cytospin preparation.Gram negative rods were observed in the cytospin preparation slide of the retention sample but no organisms were observed from the direct drop.Likewise for the return samples, gram negative rods were found in cytospin preparation but no organisms were seen in the direct drop slide.Additional retention tubes were incubated at 33-37°c for three days and then moved to a 55-60°c incubator for an additional seven days.No microbial growth in the form of turbidity in the media was observed after neither the 33-37°c incubation period nor the 55-60°c incubation period.After the 55-60°c incubation, tubes were gram stained, by direct drop, and then plated to non-selective media that was incubated at 33-37°c and 55-60°c for an additional seven days.The gram stains did not show any significant increase in organisms seen compared to non-incubated stains and no microbial growth was observed in any of the plates.Though non-viable organisms were observed in some of the gram stains, this is not an unexpected observation.Bd will continue to trend complaints for contamination or non-viables.This complaint cannot be confirmed.H3 other text : see section h.10.
 
Event Description
Customer reported that the bd bbl¿ thioglycollate medium had non-viable organisms (long thin gram negative rods) seen in the gram stains of patient samples.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1, AND HEMIN
Type of Device
MULTIPURPOSE CULTURE MEDIUM
Manufacturer (Section D)
BECTON, DICKINSON & CO.
250 schilling circle
cockeysville MD 21030
MDR Report Key8935699
MDR Text Key155850089
Report Number1111096-2019-00115
Device Sequence Number1
Product Code JSG
Combination Product (y/n)N
PMA/PMN Number
K803023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date05/20/2020
Device Catalogue Number221788
Device Lot Number9150847
Initial Date Manufacturer Received 08/15/2019
Initial Date FDA Received08/27/2019
Supplement Dates Manufacturer Received08/15/2019
Supplement Dates FDA Received02/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-